{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,8]],"date-time":"2026-02-08T10:53:53Z","timestamp":1770548033667,"version":"3.49.0"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2015,10,20]],"date-time":"2015-10-20T00:00:00Z","timestamp":1445299200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Strahlenther Onkol"],"published-print":{"date-parts":[[2016,1]]},"DOI":"10.1007\/s00066-015-0909-0","type":"journal-article","created":{"date-parts":[[2015,10,20]],"date-time":"2015-10-20T08:37:38Z","timestamp":1445330258000},"page":"55-62","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["Undetected human papillomavirus DNA and uterine cervical carcinoma","Unentdeckte humane Papillomavirus-DNA und Zervixkarzinom"],"prefix":"10.1007","volume":"192","author":[{"given":"Kae","family":"Okuma","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hideomi","family":"Yamashita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Terufumi","family":"Yokoyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keiichi","family":"Nakagawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kei","family":"Kawana","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,10,20]]},"reference":[{"key":"909_CR1","first-page":"55","volume":"1288","author":"H Hausen zur","year":"1996","unstructured":"zur Hausen H (1996) A major cause of human cancers. Biochim Biophys Acta 1288:55\u201378","journal-title":"Biochim Biophys Acta"},{"key":"909_CR2","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/S0140-6736(87)91072-5","volume":"2","author":"EM Villiers de","year":"1987","unstructured":"de Villiers EM, Wagner D, Schneider A et al (1987) Human papillomavirus infections in women with and without abnormal cervical cytology. Lancet 2:703\u2013706","journal-title":"Lancet"},{"key":"909_CR3","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1002\/(SICI)1096-9896(199909)189:1<12::AID-PATH431>3.0.CO;2-F","volume":"189","author":"JM Walboomers","year":"1999","unstructured":"Walboomers JM, Jacobs MV, Manos MM et al (1999) Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 189:12\u201319","journal-title":"J Pathol"},{"key":"909_CR4","doi-asserted-by":"crossref","first-page":"S11","DOI":"10.1016\/j.vaccine.2006.05.111","volume":"24","author":"DM Parkin","year":"2006","unstructured":"Parkin DM, Bray F (2006) Chapter 2: the burden of HPV-related cancers. Vaccine 24:S11\u2013S25","journal-title":"Vaccine"},{"key":"909_CR5","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.1016\/j.ajog.2004.06.088","volume":"191","author":"Y Nagai","year":"2004","unstructured":"Nagai Y, Toma T, Moromizato H et al (2004) Persistence of human papillomavirus infection as a predictor for recurrence in carcinoma of the cervix after radiotherapy. Am J Obstet Gynecol 191:1907\u20131913","journal-title":"Am J Obstet Gynecol"},{"key":"909_CR6","unstructured":"Badaracco G, Savarese A, Micheli A, Rizzo C, Paolini F, Carosi M, Cutillo G, Vizza E, Arcangeli G, Venuti A (2010) Persistence of HPV after radio-chemotherapy in locally advanced cervical cancer. Oncol Rep 23:1093\u20131099"},{"key":"909_CR7","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1128\/JCM.38.1.357-361.2000","volume":"38","author":"PE Gravitt","year":"2000","unstructured":"Gravitt PE, Peyton CL, Alessi TQ, Wheeler CM, Coutlee F, Hildesheim A, Schiffman MH, Scott DR, Apple RJ (2000) Improved amplification of genital human papillomaviruses. J Clin Microbiol 38:357\u2013361","journal-title":"J Clin Microbiol"},{"key":"909_CR8","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1093\/jnci\/90.1.43","volume":"90","author":"C Ngelangel","year":"1998","unstructured":"Ngelangel C, Munoz N, Bosch FX et al (1998) Causes of cervical cancer in the Philippines: a case control study. J Natl Cancer Inst 90:43\u201349","journal-title":"J Natl Cancer Inst"},{"key":"909_CR9","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1093\/jnci\/90.1.50","volume":"90","author":"S Chichareon","year":"1998","unstructured":"Chichareon S, Herrero R, Munoz N et al (1998) Risk factors for cervical cancer in Thailand: a case-control study. J Natl Cancer Inst 90:50\u201357","journal-title":"J Natl Cancer Inst"},{"key":"909_CR10","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1002\/(SICI)1096-9896(199909)189:1<12::AID-PATH431>3.0.CO;2-F","volume":"189","author":"JMM Walboomers","year":"1999","unstructured":"Walboomers JMM, Jacobs MV, Manos MM et al (1999) Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 189:12\u201319","journal-title":"J Pathol"},{"key":"909_CR11","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1002\/1097-0142(20010101)91:1<80::AID-CNCR11>3.0.CO;2-E","volume":"91","author":"H Ishikawa","year":"2001","unstructured":"Ishikawa H, Mitsuhashi N, Sakurai H et al (2001) The effects of p53 status and human papillomavirus infection on the clinical outcome of patients with stage IIIB cervical carcinoma treated with radiation therapy alone. Cancer 91:80\u201389","journal-title":"Cancer"},{"key":"909_CR12","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1016\/S0360-3016(01)02796-1","volume":"52","author":"Y Harima","year":"2002","unstructured":"Harima Y, Sawada S, Nagata K et al (2002) Human papillomavirus (HPV) DNA associated with prognosis of cervical cancer after radiotherapy. Int J Radiat Oncol Biol Phys 52:1345\u20131351","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"909_CR13","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1002\/ijc.10708","volume":"102","author":"B Bachtiary","year":"2002","unstructured":"Bachtiary B, Obermair A, Dreier P et al (2002) Impact of multiple HPV infection on response to treatment and survival in patients receiving radical radiotherapy for cervical cancer. Int J Cancer 102:237\u2013243","journal-title":"Int J Cancer"},{"key":"909_CR14","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1111\/j.1525-1438.2005.15216.x","volume":"15","author":"K Lindel","year":"2005","unstructured":"Lindel K, Burri P, Studer HU et al (2005) Human papillomavirus status in advanced cervical cancer: predictive and prognostic significance for curative radiation treatment. Int J Gynecol Cancer 15:278\u2013284","journal-title":"Int J Gynecol Cancer"},{"key":"909_CR15","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1002\/ijc.25741","volume":"15","author":"YJ Song","year":"2011","unstructured":"Song YJ, Kim JY, Lee SK et al (2011) Persistent human papillomavirus DNA is associated with local recurrence after radiotherapy of uterine cervical cancer. Int J Cancer 15:896\u2013902","journal-title":"Int J Cancer"},{"key":"909_CR16","doi-asserted-by":"crossref","first-page":"940","DOI":"10.5858\/2003-127-940-HPTM","volume":"127","author":"RA Hubbard","year":"2003","unstructured":"Hubbard RA (2003) Human Papillomavirus testing methods. Arch Pathol Lab Med 127:940\u2013945","journal-title":"Arch Pathol Lab Med"},{"key":"909_CR17","first-page":"1038","volume":"13","author":"SM Wilting","year":"2012","unstructured":"Wilting SM, Snijderes PJ, Varlaat W et al (2012) Altered micro RNA expression associated with chromosomal changes contributes to cervical carcinogenesis. Oncogene 13:1038","journal-title":"Oncogene"},{"key":"909_CR18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/jmv.1890460102","volume":"46","author":"J Konya","year":"1995","unstructured":"Konya J, Veress G, Hernadi Z et al (1995) Correlation of human papillomavirus 16 and 18 with prognostic factors in invasive cervical neoplasias. J Med Virol 46:1\u20136","journal-title":"J Med Virol"},{"key":"909_CR19","doi-asserted-by":"crossref","first-page":"1935","DOI":"10.1002\/(SICI)1097-0142(19961101)78:9<1935::AID-CNCR14>3.0.CO;2-Z","volume":"78","author":"S Nakagawa","year":"1996","unstructured":"Nakagawa S, Yoshikawa H, Onda T et al (1996) Type of human papillomavirus is related to clinical features of cervical carcinoma. Cancer 78:1935\u20131941","journal-title":"Cancer"},{"key":"909_CR20","doi-asserted-by":"crossref","first-page":"2613","DOI":"10.1200\/JCO.1998.16.8.2613","volume":"16","author":"I Lombard","year":"1998","unstructured":"Lombard I, Vincent-Salomon A, Validire P et al (1998) Human papillomavirus genotype as a major determinant of the course of cervical cancer. J Clin Oncol 16:2613\u20132619","journal-title":"J Clin Oncol"},{"key":"909_CR21","first-page":"4145","volume":"9","author":"SS Im","year":"2003","unstructured":"Im SS, Wilczynski SP, Burger RA, Monk BJ (2003) Early stage cervical cancers containing human papillomavirus type 18 DNA have more nodal metastasis and deeper stromal invasion. Clin Cancer Res 9:4145\u20134150","journal-title":"Clin Cancer Res"},{"key":"909_CR22","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1002\/ijc.2910640312","volume":"64","author":"J Czegledy","year":"1995","unstructured":"Czegledy J, Iosif C, Hansson BG et al (1995) Can a test for E6\/E7 transcripts of human papillomavirus type 16 serve as a diagnostic tool for the detection of micrometastasis in cervical cancer? Int J Cancer 64:211\u2013215","journal-title":"Int J Cancer"},{"key":"909_CR23","doi-asserted-by":"crossref","first-page":"128","DOI":"10.5114\/jcb.2015.50720","volume":"7","author":"K Okuma","year":"2015","unstructured":"Okuma K, Yamashita H, Kobayashi R, Nakagawa K (2015) A study of high-dose-rate intracavitary brachytherapy boost for curative treatment of uterine cervical cancer. J Contemp Brachytherapy 7:128\u2013134","journal-title":"J Contemp Brachytherapy"},{"key":"909_CR24","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.ygyno.2006.06.034","volume":"104","author":"K Yoshinaga","year":"2007","unstructured":"Yoshinaga K, Niikura H, Ogawa Y, Nemoto K, Nagase S, Takano T, Ito K, Yaegashi N (2007) Phase I trial of concurrent chemoradiation with weekly nedaplatin in patients with squamous cell carcinoma of the uterine cervix. Gynecol Oncol 104:36\u201340","journal-title":"Gynecol Oncol"}],"container-title":["Strahlentherapie und Onkologie"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00066-015-0909-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00066-015-0909-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00066-015-0909-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,23]],"date-time":"2022-05-23T18:00:13Z","timestamp":1653328813000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00066-015-0909-0"}},"subtitle":["Association with cancer recurrence","Zusammenhang mit einem Krebsrezidiv"],"short-title":[],"issued":{"date-parts":[[2015,10,20]]},"references-count":24,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,1]]}},"alternative-id":["909"],"URL":"https:\/\/doi.org\/10.1007\/s00066-015-0909-0","relation":{},"ISSN":["0179-7158","1439-099X"],"issn-type":[{"value":"0179-7158","type":"print"},{"value":"1439-099X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,10,20]]}}}